Abstract
Targeted therapies are all the rage in oncology research these days. The problem remains as to how to confirm that the target is actually being hit in vivo. This report describes the application of phospho-specific flow cytometry to establish in vivo target inhibition in real time.
Original language | English (US) |
---|---|
Pages (from-to) | 1493-1495 |
Number of pages | 3 |
Journal | Clinical Cancer Research |
Volume | 18 |
Issue number | 6 |
DOIs | |
State | Published - Mar 15 2012 |
ASJC Scopus subject areas
- Oncology
- Cancer Research